Global In-Vivo CRO Market
The Global In-Vivo CRO Market was valued at USD 2.85 Billion in 2021 which expected to reach USD 6.8 Billion by 2027 at a CAGR 8% from 2022-2027.
Report on "In-Vivo CRO Market" 2022-2027 Report helps to Development Strategy for Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, by regions, by consumers and also their price change details. As an in-depth Analysis report, it covers all key attributes analysis & opinion for In-vivo CRO Industry. Likewise, the report reviews key companies involved in In-vivo CRO and enlists all their major & minor projects.
The report focuses on the In-Vivo CRO market size, segment size (mainly covering type, GLP Type, indication and region), competitor landscape, recent status, and development trends. Furthermore, the report provides detailed cost analysis, supply chain. Technological innovation & advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Consumer behavior analysis & market dynamics (drivers, market restraints, opportunities) provides crucial information for knowing the In-vivo CRO market.
Considering the influence of COVID-19 on the global In-Vivo CRO market, this report analyzed the impact from both global & regional perspectives. From production end to consumption end in regions such as North America, Europe, Asia Pacific, the report put emphasis on analysis of market under COVID-19 & corresponding response policy in different regions.
Key Players:
TOP MANUFACTURERS Listed in The In-Vivo CRO Market Report Are: Covance, Inc., Theorem Clinical Research, WuXi AppTec, Inc., inVentiv Health, Evotec (US), Inc., Charles River Laboratories, American Preclinical Services, LLC., MELIOR DISCOVERY, Iris Pharma, etc.
By Taxonomy
By Type
By GLP Type
By Indication
Global In-Vivo CRO Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global In-Vivo CRO Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global In-Vivo CRO Market, By Type
5.1 Y-o-Y Growth Comparison, By Type
5.2 Global In-Vivo CRO Market Share Analysis, By Type
5.3 Global In-Vivo CRO Market Size and Forecast, By Type
5.3.1 Rodent Based (Rats, Mice, Others)
5.3.2. Non-Rodent Based
6 Global In-Vivo CRO Market, By GLP Type
6.1 Y-o-Y Growth Comparison, By GLP Type
6.2 Global In-Vivo CRO Market Share Analysis, By GLP Type
6.3 Global In-Vivo CRO Market Size and Forecast, By GLP Type
6.3.1 Non GLP (Inhouse, Outsourcing)
6.3.2 GLP Toxicology (Inhouse, Outsourcing)
7 Global In-Vivo CRO Market, By Indication
7.1 Y-o-Y Growth Comparison, By Indication
7.2 Global In-Vivo CRO Market Share Analysis, By Indication
7.3 Global In-Vivo CRO Market Size and Forecast, By Indication
7.3. 1 Autoimmune/Inflammation Conditions
7.3.2. Pain Management
7.3.3. Oncology
7.3.4. CNS Conditions
8 Global In-Vivo CRO Market, By Region
8.1 Global In-Vivo CRO Market Share Analysis, By Region
8.2 Global In-Vivo CRO Market Share Analysis, By Region
8.3 Global In-Vivo CRO Market Size and Forecast, By Region
9 North America In-Vivo CRO Market Analysis and Forecast (2022-2027)
9.1 Introduction
9.2 North America In-Vivo CRO Market Share Analysis, By Type
9.3 North America In-Vivo CRO Market Size and Forecast, By GLP Type
9.4 North America In-Vivo CRO Market Size and Forecast, By Indication
9.5 North America In-Vivo CRO Market Size and Forecast, By Country
9.5.1 U.S.
9.5.2 Canada
9.5.3 Mexico
10 Europe In-Vivo CRO Market Analysis and Forecast (2022-2027)
10.1 Introduction
10.2 Europe In-Vivo CRO Market Share Analysis, By Type
10.3 Europe In-Vivo CRO Market Size and Forecast, By GLP Type
10.4 Europe In-Vivo CRO Market Size and Forecast, By Indication
10.5 Europe In-Vivo CRO Market Size and Forecast, By Country
10.5.1 Germany
10.5.2 France
10.5.3 UK
10.54. Rest of Europe
11 Asia Pacific In-Vivo CRO Market Analysis and Forecast (2022-2027)
11.1 Introduction
11.2 Asia Pacific In-Vivo CRO Market Share Analysis, By Type
11.3 Asia Pacific In-Vivo CRO Market Size and Forecast, By GLP Type
11.4 Asia Pacific In-Vivo CRO Market Size and Forecast, By Indication
11.5 Asia Pacific In-Vivo CRO Market Size and Forecast, By Country
11.5.1 China
11.5.2 Japan
11.5.3 India
11.5.4. Rest of Asia Pacific
12 Latin America In-Vivo CRO Market Analysis and Forecast (2022-2027)
12.1 Introduction
12.2 Latin America In-Vivo CRO Market Share Analysis, By Type
12.3 Latin America In-Vivo CRO Market Size and Forecast, By GLP Type
12.4 Latin America In-Vivo CRO Market Size and Forecast, By Indication
12.5 Latin America In-Vivo CRO Market Size and Forecast, Country
12.5.1. Brazil
12.5.2. Rest of Latin America
13 Middle East In-Vivo CRO Market Analysis and Forecast (2022-2027)
13.1 Introduction
13.2 Middle East In-Vivo CRO Market Share Analysis, By Type
13.3 Middle East In-Vivo CRO Market Size and Forecast, By GLP Type
13.4 Middle East In-Vivo CRO Market Size and Forecast, By Indication
13.5 Middle East In-Vivo CRO Market Size and Forecast, By Country
13.5.1. Saudi Arabia
13.5.2. UAE
13.5.3. Egypt
13.5.4. Kuwait
13.5.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Covance, Inc
15.1.1 Overview
15.1.2 Offerings
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Theorem Clinical Research
15.2.1 Overview
15.2.2 Offerings
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. WuXi AppTec, Inc
15.3.1 Overview
15.3.2 Offerings
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 inVentiv Health
15.4.1 Overview
15.4.2 Offerings
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Evotec (US), Inc
15.5.1 Overview
15.5.2 Offerings
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Charles River Laboratories
15.6.1 Overview
15.6.2 Offerings
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
15.7 American Preclinical Services, LLC
15.7.1 Overview
15.7.2 Offerings
15.7.3 Key Financials
15.7.4 Business Segment & Geographic Overview
15.7.5 Key Market Developments
15.7.6 Key Strategies
15.8 MELIOR DISCOVERY
15.8.1 Overview
15.8.2 Offerings
15.8.3 Key Financials
15.8.4 Business Segment & Geographic Overview
15.8.5 Key Market Developments
15.8.6 Key Strategies
15.9.1 Overview
15.9.2 Offerings
15.9.3 Key Financials
15.9.4 Business Segment & Geographic Overview
15.9.5 Key Market Developments
15.9.6 Key Strategies
